To Cure Together

We’re ADC specialists focused on doing one thing brilliantly.

Outsmarting cancer.

To Cure Together

We’re ADC specialists focused on doing one thing brilliantly.

Outsmarting cancer.

ONE OBJECTIVE.

SINCE 2010.

ADC BIO is an innovative biotechnology company. Specialising in Antibody Drug Conjugates.

We’re developing new process technology. To speed, simplify and significantly lower the production costs of the latest generation of anticancer blockbuster ADC drugs.

JOIN US FOR THE JOURNEY
ADC Bio

TECHNOLOGY

LOCK-RELEASE.

TARGETING DISEASE.
WITH PRECISION.

ADC BIO’s proprietary Lock-Release technology is a fast, simple, cost efficient and robust system to guarantee ADCs of a consistently high quality and purity.

DISCOVER THE BENEFITS

BIO-CONJUGATION SERVICES.

We’re nimble, flexible and focused on helping ADC drug developers bring the next generation of anticancer drugs to life.

3-arrows

NEWS

ADC Bio secures £1.14m investment from Downing LLP

ADC Biotechnology has successfully secured a £1.14m investment from Downing LLP to finance innovative bioconjugation and their US expansion plans

READ PRESS RELEASE

CAREERS

GREAT MINDS.
THINKING ALIKE.

JOIN THE TEAM.

WE'RE HIRING